Inter-individual Variability in Levels of Human Microsomal Protein and Hepatocellularity per Gram of Liver Publication Inter-individual Variability in Levels of Human Microsomal Protein and Hepatocellularity per Gram of Liver This study sought to determine levels of microsomal protein (MPPGL) and hepatocellularity (HPGL) per gram…Danielle Pillsbury2013年10月1日
Differential Pharmacokinetics of Ganitumab in Patients with Metastatic Pancreatic Cancer Versus Other Advanced Solid Cancers Publication Differential Pharmacokinetics of Ganitumab in Patients with Metastatic Pancreatic Cancer Versus Other Advanced Solid Cancers Ganitumab is an investigational, fully human monoclonal antibody antagonist of the insulin-like growth factor-1 receptor…Danielle Pillsbury2013年10月1日
Exposure-response Analysis of Pertuzumab in HER2-positive Metastatic Breast Cancer: Absence of Effect on QTc Prolongation and Other ECG Parameters Publication Exposure-response Analysis of Pertuzumab in HER2-positive Metastatic Breast Cancer: Absence of Effect on QTc Prolongation and Other ECG Parameters The phase III trial of pertuzumab plus trastuzumab plus docetaxel versus placebo plus trastuzumab plus…Danielle Pillsbury2013年9月3日
Toxicokinetics/Toxicodynamics of γ-hydroxybutyrate-ethanol Intoxication: Evaluation of Potential Treatment Strategies Publication Toxicokinetics/Toxicodynamics of γ-hydroxybutyrate-ethanol Intoxication: Evaluation of Potential Treatment Strategies γ-Hydroxybutyrate (GHB), a common drug of abuse, is often coingested with ethanol. Increasing renal clearance…Danielle Pillsbury2013年9月1日
Pharmacokinetics of a Three-way Drug Interaction Between Danoprevir, Ritonavir, and the Organic Anion Transporting Polypeptide (OATP) Inhibitor Ciclosporin Publication Pharmacokinetics of a Three-way Drug Interaction Between Danoprevir, Ritonavir, and the Organic Anion Transporting Polypeptide (OATP) Inhibitor Ciclosporin Danielle Pillsbury2013年9月1日
Application of Permeability-limited Physiologically-based Pharmacokinetic Models: Part I—Digoxin Pharmacokinetic Incorporating P-glycoprotein-mediated Efflux Publication Application of Permeability-limited Physiologically-based Pharmacokinetic Models: Part I—Digoxin Pharmacokinetic Incorporating P-glycoprotein-mediated Efflux A prerequisite for the prediction of the magnitude of P-glycoprotein (P-gp)-mediated drug-drug interactions between digoxin…Danielle Pillsbury2013年9月1日
Application of Permeability-limited Physiologically-based Pharmacokinetic Models: Part II—Prediction of P-glycoprotein Mediated Drug-drug Interactions with Digoxin Publication Application of Permeability-limited Physiologically-based Pharmacokinetic Models: Part II—Prediction of P-glycoprotein Mediated Drug-drug Interactions with Digoxin Digoxin is the recommended substrate for assessment of P-glycoprotein (P-gp)-mediated drug-drug interactions (DDIs) in vivo.…Danielle Pillsbury2013年9月1日
Using Historical Control Information for the Design and Analysis of Clinical Trials with Overdispersed Count Data Publication Using Historical Control Information for the Design and Analysis of Clinical Trials with Overdispersed Count Data Results from clinical trials are never interpreted in isolation. Previous studies in a similar setting…Danielle Pillsbury2013年9月1日
Siponimod for Patients with Relapsing-remitting Multiple Sclerosis (BOLD): An Adaptive, Dose-ranging, Randomized, Phase 2 Study Publication Siponimod for Patients with Relapsing-remitting Multiple Sclerosis (BOLD): An Adaptive, Dose-ranging, Randomized, Phase 2 Study Siponimod is an oral selective modulator of sphingosine 1-phosphate receptor types 1 and type 5,…Danielle Pillsbury2013年9月1日
Accounting for Transporters in Renal Clearance: Towards a Mechanistic Kidney Model (Mech KiM) Publication Accounting for Transporters in Renal Clearance: Towards a Mechanistic Kidney Model (Mech KiM) The impact of transporters in modulating the disposition of drugs in the liver and their…Danielle Pillsbury2013年8月20日